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Asthma is a common respiratory condition associated with a
signiﬁcant socioeconomic burden affecting 300 million peo-
ple worldwide. Environmental factors and, in children, viral
respiratory infections have been associated with acute exacer-
bations of asthma.1 Although the impact of viral infections in
adults is less clear with regard to asthma exacerbation, stud-
ies suggest that viral infections are involved in about 50% of
adult asthma episodes.
We  conducted a descriptive, observational, cohort study in
47 patients (38 female and 9 male) previously diagnosed with
asthma, who  attended the Hospital Universitário Clementino
Fraga Filho (HUCFF)/Federal University of Rio de Janeiro (UFRJ)
between August 2010 and November 2012. Median age was
50.2 years, ranging from 21 to 80 years. Respiratory samples
(nasal/throat swabs) were obtained from participants during
routine visit to the clinic and whenever the patients visited
the hospital due to asthma exacerbation. Sixty-seven samples
were collected during an episode of asthma exacerbation and
63 in the absence of asthma symptoms. Asthma severity was
classiﬁed as mild (52.2%; n = 35) and moderate/severe (47.8%;
n = 32). Each patient provided at least one sample during an
asthma episode and one sample in the absence of asthma
symptoms. The study protocol was approved by the Ethics
Committee of the HUCFF/UFRJ, Rio de Janeiro, Brazil (protocol
number 011/10) and informed consent was obtained from
all participants before the start of the study. The specimens
were tested by real time or conventional PCR for presence
of respiratory viruses. Statistical analysis was performed
using Minitab® for Windows Release 16.0 (Minitab Inc., State
College, PA, USA).
Eighteen patients (38.3%) tested positive for respiratory
viruses at least once during the study; no respiratory viruses
were detected in the absence of asthma symptoms. Of the
67 samples collected during asthma episodes, 20 (29.9%) were
positive for respiratory viruses, namely six HAdV, six HBoV2,
two HRV-A/B, two FLUVB, and one HRV-C, HRSV, and HMPV.
HAdV, KIPyV, and HRV-A/B co-infections were detected in one
sample. FLUVA, HPIV1-4, HCoV, HBoV1 3 and 4, and WUPyV
were not detected in any of the samples examined (Table 1).
One patient had two samples positive for HBoV2 and anotherpatient had one sample positive for HRV-A/B and one for
HBoV2 (Table 1). No samples collected in the absence of
asthma symptoms tested positive for the viruses screened.
A statistically signiﬁcant association between Severity of the
asthma episode was signiﬁcantly associated with viral infec-
tion: 42.4% of the patients with a severe/moderate asthma
episode were positive for viral infection compared to 16.7%
of patients with mild episodes (p = 0.015). The relative risk for
viral infection in asthmatic patients in this study was found
to be 2.34 (95% CI: 1.88–2.90). These data suggested that viral
infections and asthma symptoms were associated, and these
infections could trigger exacerbation of the disease. Indeed,
the data demonstrated that an individual suffering from a
viral infection were 2.34 times as likely to develop moderate
or severe asthma.
In our study only nine out of 47 patients were male. Many
epidemiological studies suggest that women are at increased
risk of developing adult-onset asthma and also suffer from
more  severe disease than men. These gender differences
appear to result from biological sex differences as well as
sociocultural and environmental differences. Biological sex
differences include genetic, pulmonary, and immunological
factors. There is compelling evidence that sex hormones are
major determinants of these biological sex differences.3
Previous studies have demonstrated an association
between asthma and infections with various respiratory
viruses, including HRSV, HRV, HMPV, HPIV, HAdV, and FLUV.4
More recently, HBoV has been isolated from patients pre-
senting with mild or severe asthma. In older children and
in adults, HRV infections accounted for more  than 50% of all
viral-triggered exacerbations.5 In the present study, HBoV and
HAdV were the most common viruses identiﬁed, accounting
for 60% (12/20) of infections compared to HRV detected in 15%
(3/20) of cases.
The management of asthma in older adults repre-
sents a substantial cost burden associated with hospital
treatment, prescriptions, health-care, and management of co-
morbidities. Viral respiratory infections can potentially trigger
asthma exacerbation in adults in general and in the elderly
in particular. Therefore, development of effective treatments
or vaccines to prevent such infections would have a signif-
icant impact on the burden of asthma as well as on other
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Table 1 – Characteristics of patients infected with respiratory viruses.
Patient Sex Age (years) Asthma attacka Date of collection Duration of symptoms (days)b Virus detected
1 F 44 MO 04/25/2011 4 HAdV
45 – 05/13/2012
2 F 45 MO 10/18/2010 >60 FLUVB
46 – 05/30/2011
46 – 11/28/2011
47 S 04/09/2012 2
3 M 31 M 08/03/2011 2 HRSV
32 – 05/05/2012
4 F 29 M 08/23/2010 15
30 MO 04/04/2011 4 HAdV
30 – 06/20/2011
30 – 08/06/2012
5 F 66 M 10/25/2010 5
67 – 07/05/2011
68 S 02/27/2012 15 HAdV
6 M 34 M 10/13/2010 4
34 M 10/18/2010 9 HBoV2
36 – 10/16/2012
7 F 30 M 10/13/2010 4 HBoV2
30 M 10/18/2010 9
30 M 02/10/2011 3
31 MO 08/18/2011 1
31 MO 09/12/2011 7 HBoV2
31 – 07/16/2012
8 F 45 MO 08/25/2010 15 HBoV2
46 – 09/14/2011
9 M 52 MO 08/11/2010 15 HAdV+KIPyV+HRV
52 – 02/20/2011
53 – 09/14/2011
10 F 78 M 04/18/2011 15 HAdV
79 – 11/28/2011
11 F 58 MO 08/09/2010 60 HBoV2
59 – 01/24/2012
60 MO 06/18/2012 7
12 F 62 S 08/24/2010 5 HRV-A/B
62 MO 04/11/2011 15
62 M 04/10/2012 15 HBoV2
63 – 05/07/2012
13 F 50 MO 03/28/2011 15 HRV-A/B
50 M 06/13/2011 1
50 – 03/21/2011
51 M 05/14/2012 30
14 F 54 MO 05/30/2011 30 HAdV
55 – 07/02/2012
15 M 57 M 10/18/2010 7
58 MO 04/22/2011 30
58 MO 10/31/2011 30 HAdV
58 – 08/22/2011 –
16 F 67 M 09/13/2010 15
68 – 10/03/2011
69 M 08/13/2012 3 HRV-C
17 F 25 MO 10/25/2010 2 HMPV
26 – 04/18/2011
18 F 48 S 08/25/2010 5 FLUVB
48 – 04/12/2011
49 – 12/13/2011
a Based on reference 2: M, mild; MO, moderate; S, severe.
b Duration of symptoms at the time of sample collection. (–), no asthma symptoms.
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respiratory diseases, such as allergic rhinitis and chronic
obstructive pulmonary disease (COPD).
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